Online ISSN: 1949-2553

Launched in 2010, Oncotarget is a peer-reviewed, multidisciplinary traditional-style journal with free access.

As a traditional journal, Oncotarget publishes papers online in the issues with the page numbers. Since August 2017, Oncotarget publishes two issues per week: on Tuesday and Friday. Final paginated issues are released to PubMed quickly and in their permanent form. Each issue/paper can be printed for special demand.

As a multidisciplinary journal, Oncotarget publishes high-impact research papers of general interest and biological significance in all fields of oncology and beyond. Oncotarget is accepting papers on the following topics beyond oncology: Gerotarget/Aging, Pathology beyond oncology, Immunology and Microbiology, Autophagy and Cell Death, Chromosome, Neuroscience, Endocrinology, Cardiology, Pharmacology (all areas) and more.

Currently, more than 19,000 Oncotarget papers are searchable on PubMed

Oncotarget is indexed in PubMed, PubMed Central, Web of Sciences/Science Citation Index Expanded, Scopus, BIOSIS Previews, Biological Abstracts, EMBASE. In all Indexes the Journal's abbreviation is Oncotarget.

According to Web of Science, Impact Factor (IF 2016) is 5.168, and 5-years IF (2016) is 5.415.

Also, according to Web of Science, Oncotarget has a high influential score, Eigenfactor, indicating its notability among all cancer journals. Namely, 2016 Eigenfactor score (a measure of influence of a scientific journal) is 9.02.

Scopus/SJR ranking: 2011-ongoing: Q1 (highest rank). All years Q1 in Medicine and Oncology category. According to Scopus, Oncotarget ranks number 1 on Total Documents (2015-2016) among all journals in Oncology.

All Oncotarget content is archived in PubMed Central.

The publisher also maintains the journal's own digital archive.

The Editorial Board represents scientists from all over the world, predominantly from the USA.

The founding Editors include Nobel Prize winner Andrew V. Schally, Lasker Award recipients Alexander Varshavsky, Brian J. Druker , Gregg L. Semenza, William G. Kaelin, Jr. and 12 Members of the US National Academy of Sciences.

Oncotarget has published outstanding papers and reviews by Bert Vogelstein, Robert Weinberg, Peter K. Vogt, Pier Paolo Pandolfi, Carlo M. Croce, Michael Karin and other outstanding scientists.

Oncotarget is now offering free Altmetric Article Reports as a new part of our journal platform to provide real-time tracking of article coverage in digital and traditional media channels, often long before traditional citations begin to accrue.

We are pleased to announce the new face of Oncotarget coming in 2018 with enhanced content delivery platform, new features and an intuitive navigation.

Oncotarget follows the COPE guidelines and ICMJE's Recommendations

Mission
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to allow exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster applications of basic and clinical science to fight disease.
IMPACT FACTOR
(IF) THOMSON REUTERS
2016 5-YR IMPACT FACTOR 5.415
2016
2015
2014
2013
2012
2011
5.168
5.008
6.359
6.627
6.636
4.784
ARCHIVING & INDEXING
  • PubMed
  • PubMed Central
  • ISI / Web of Science: Science Citation Index Expanded
  • Scopus
  • Biological Abstracts
  • BIOSIS Previews
  • EMBASE
Editoral
For editorial inquiries, please call us or contact us
Production
For questions related to preparation of your article for publication, please call us or contact us
External & Legal
If you have questions about the indexing status of your paper, please contact us
Reprints
Each issue or paper can be printed on demand. To make a reprint request, please call us or contact us
Billing & Payments
If you have questions about billing/invoicing or would like to make a payment, please call us or contact us
Online ISSN: 1945-4589

Launched in 2009, Aging is a peer-reviewed, traditional-style, monthly journal with free access.

As a Traditional journal, Aging publishes papers online in monthly issues with the page numbers. Each issue/paper can be printed for special demand.

Accepted papers appear online and PubMed very quickly.

Aging is indexed in PubMed/Medline (abbreviated as Aging (Albany NY) , PubMed Central, Web of Sciences/Science Citation Index Expanded (abbreviated as Aging-US), Scopus (abbreviated as Aging), BIOSIS Previews, Biological Abstracts, EMBASE.

All Aging content is archived in PubMed Central.

The publisher also maintains the journal's own digital archive.

Aging publishes high-impact research papers of general interest and biological significance in all fields of aging research including but not limited to cellular senescence, DNA damage and repair, organismal aging, age-related diseases, genetic control of aging from yeast to mammals, regulation of longevity, evolution of aging, anti-aging strategies and drug development and especially the role of signal transduction pathways in aging and potential approaches to modulate these signaling pathways to extend lifespan.

Also, Aging covers many other topics (beyond traditional gerontology) including cellular and molecular biology (regulation of translation, cell growth, death and autophagy, mitochondria, microRNAs, stem cells), human age-related diseases, pathology in model organisms, cancer and signal transduction pathways (p53, sirtuins, PI-3K/AKT/mTOR and so on) and approaches to modulate these signaling pathways.

The Aging Editorial Board represents scientists from all over the world, predominantly from the USA. Among them are Cynthia Kenyon, Ronald A. DePinho, Arnold Levine, Leonard Guarente, Michael Hall and other outstanding scientists. The Board includes six members of the National Academy of Sciences (USA), Lasker and Nobel Award recipients (Elizabeth H. Blackburn). It also includes the directors of some of the largest American cancer centers, directors of research from the most prominent pharmaceutical companies, professors from prestigious Universities, Editors of leading journals, and other prolific and distinguished scientists.

Aging has published outstanding papers and reviews by Lawrence Donehower, Toren Finkel, Stephen Helfand, Gerald Shadel, Andre Nussenzweig, Maurice Burg, Karen Vousden, Leonard Guarente and other highly cited authors.

Elizabeth Blackburn, a member of the Editorial Board of Aging, won the Nobel Prize in Physiology or Medicine 2009, while being a member of the Board. Elizabeth Blackburn co-authored a paper published in the first (inaugural) issue of Aging.

Andrew V. Schally, Nobel Prize Laureate, published his paper in Aging.

Shinya Yamanaka won the Nobel Prize in Physiology and Medicine 2012. Shinya Yamanaka co-authored paper published in Aging.

Aging is now offering Free Altmetric Article Reports as a new part of our Journal platform to provide real-time tracking of article coverage in digital and traditional media channels, often long before traditional citations begin to accrue.

We are pleased to announce the new face of Aging coming in 2018 with enhanced content delivery platform, new features and an intuitive navigation.

Aging follows the COPE guidelines and ICMJE's Recommendations

Our mission is to share novel scientific discoveries across all fields of age-related research. We welcome scientists of all disciplines, not only those in traditional gerontology. We aim to spread knowledge of the mechanisms surrounding aging and age-related disease, and ultimately seek to understand how to modulate these pathways to extend healthy life.

Mission
Our mission Is to share novel scientific discoveries across oil fields of age-related research. We welcome scientists of all disciplines, not only those in traditional gerontology. We aim to spread knowledge of the mechanisms surrounding aging and age-related disease, and ultimately seek to understand how to modulate these pathways to extend healthy life.
IMPACT FACTOR
(IF) THOMSON REUTERS
2016 5-YR IMPACT FACTOR 5.240
2016
2015
2014
2013
2012
2011
4.867
3.979
6.432
4.886
4.696
5.127
ARCHIVING & INDEXING
  • PubMed/Medline (abbreviated as "Aging (Albany NY)")
  • PubMed Central
  • Web of Science/Science Citation Index Expanded (abbreviated as Aging-US) & listed in the Cell Biology-SCIE and Geriatrics & Gerontology category
  • Scopus /Rank Q1(the highest rank) (abbreviated as Aging)- Aging and Cell Biology category
  • Biological Abstracts
  • BIOSIS Previews
  • EMBASE
Editoral
For editorial inquiries, please call us or contact us
Production
For questions related to preparation of your article for publication, please call us or contact us
External & Legal
If you have questions about the indexing status of your paper, please contact us
Reprints
Each issue or paper can be printed on demand. To make a reprint request, please call us or contact us
Billing & Payments
If you have questions about billing/invoicing or would like to make a payment, please call us or contact us
Online ISSN: 2331-4737

Launched in 2014, Oncoscience is a peer-reviewed, traditional-style, bi-monthly journal with free access. Oncoscience has also a special mission: Freeing oncology from publication cost. It is free for the readers and the authors.

As a Traditional journal, Oncoscience publishes papers on line in the issues with the page numbers. Each issue/paper can be printed for special demand.

All Oncoscience content is archived in PubMed Central.

The publisher also maintains the journal's own digital archive.

Oncoscience is indexed/abstracted in PubMed, PubMed Central, Scopus (Oncology category), EMBASE.

Oncoscience covers the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. Cancer research has entered a new phase where the convergence of information from different disciplines (cancer biology, bioinformatics, chemistry and drug design etc) are beginning to provide new knowledge into tumor development and cancer treatment. To capture with this phase, Oncoscience covers all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes, their role in signal transduction and the mechanisms by which their expression and function are altered during tumor development. In addition to publishing manuscripts that directly relate to these areas of research, the journal covers the niche of interdisciplinary articles, bringing together cancer biology, chemistry and drug design.

Oncoscience also publishes on a regular basis Editorials on emergent topics and commentaries on highly visible papers published in other journals.

Its International editorial board includes 65 members from different countries (USA (predominant country), United Kingdom, Sweden, France, Denmark, Spain), the most highly cited authors, professors of the leading universities, supported by more than 100 NIH grants. Editorial Board includes 20 members of the National Academy of Sciences (USA), 6 Lasker Award recipients (Brian Druker, Andrew Schally, Alexander Varshavsky, Stephen J. Elledge, William G. Kaelin,Jr. and Greg L. Semenza) and a Nobel Prize winner Andrew Schally.

Our authors are from more 25 countries from different continents.

Oncoscience is now offering Free Altmetric Article Reports as a new part of our Journal platform to provide real-time tracking of article coverage in digital and traditional media channels, often long before traditional citations begin to accrue.

We are pleased to announce the new face of Oncoscience coming in 2018 with enhanced content delivery platform, new features and an intuitive navigation.

Oncoscience always follows the COPE guidelines and ICMJE's Recommendations

Mission
Our mission is to cover the rapidly growing field of cancer research. We aim to elaborate on emergent topics not currently covered by other journals.

Oncoscience has also a special mission: Freeing oncology from publication cost. It is free for the readers and the authors.

ARCHIVING & INDEXING
  • PubMed
  • PubMed Central
  • Scopus (Oncology category)
  • EMBASE
Editoral
For editorial inquiries, please call us or contact us
Production
For questions related to preparation of your article for publication, please call us or contact us
External & Legal
If you have questions about the indexing status of your paper, please contact us
Reprints
Each issue or paper can be printed on demand. To make a reprint request, please call us or contact us
Billing & Payments
If you have questions about billing/invoicing or would like to make a payment, please call us or contact us
Online ISSN: 1947-6027
Genes & Cancer (formerly a SAGE publication) was acquired in 2014. It is as a peer-reviewed journal, traditional-style, bi-monthly journal with free access.

As a traditional journal, Genes & Cancer publishes papers on line in the issues with the page numbers. Each issue/paper can be printed for special demand.

Advance papers are usually published online several days after acceptance. All Genes & Cancer content is archived in PubMed Central.

The publisher also maintains the journal's own digital archive.

Genes & Cancer is indexed/abstracted in PubMed , PubMed Central, Scopus (Cancer Research category, Q1 rank), EMBASE.

The journal covers all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes, their role in signal transduction and the mechanisms by which their expression and function are altered during tumor development. Genes & Cancer aims to capture the excitement of the new phases of cancer research through genomics, bioinformatics and modern genetics.

Genes & Cancer is now offering Free Altmetric Article Reports as a new part of our Journal platform to provide real-time tracking of article coverage in digital and traditional media channels, often long before traditional citations begin to accrue.

We are pleased to announce the new face of Genes & Cancer coming in 2018 with enhanced content delivery platform, new features and an intuitive navigation.

Genes & Cancer always follows the COPE guidelines and ICMJE's Recommendations

Genes & Cancer is a member of the Committee on Publication Ethics (COPE)

Mission
Our mission is to combine research from the fields of genomics, bioinformatics, and modem genetics to determine how cancer cells overcome growth regulatory pathways. We aim to cover all aspects of oncogenes, growth suppressor and apoptotic genes, and their roles in tumor development
ARCHIVING & INDEXING
  • PubMed
  • PubMed Central
  • Scopus/Q1 rank (the highest) - Cancer Research category
  • EMBASE
Editoral
For editorial inquiries, please call us or contact us
Production
For questions related to preparation of your article for publication, please call us or contact us
External & Legal
If you have questions about the indexing status of your paper, please contact us
Reprints
Each issue or paper can be printed on demand. To make a reprint request, please call us or contact us
Billing & Payments
If you have questions about billing/invoicing or would like to make a payment, please call us or contact us